Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer

類似資料

• The genetic landscape and clonal evolution of breast cancer resistance to palbociclib plus fulvestrant in the PALOMA-3 trial
  著者:: O’Leary, Ben, 等
  出版事項: (2018)
• Early circulating tumor DNA dynamics and clonal selection with palbociclib and fulvestrant for breast cancer
  著者:: O’Leary, Ben, 等
  出版事項: (2018)
• Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA‐3 Results
  著者:: Loibl, Sibylle, 等
  出版事項: (2017)
• Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor–Positive Metastatic Breast Cancer
  著者:: Turner, Nicholas C., 等
  出版事項: (2019)
• Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3)
  著者:: Verma, Sunil, 等
  出版事項: (2016)